DermTech, Inc is a diagnostics & research business based in the US. DermTech shares (DMTK) are listed on the NASDAQ and all prices are listed in US Dollars. DermTech employs 114 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in DermTech
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – DMTK – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
DermTech stock price (NASDAQ: DMTK)Use our graph to track the performance of DMTK stocks over time.
DermTech shares at a glance
|Latest market close||$40.92|
|52-week range||$10.00 - $84.49|
|50-day moving average||$39.29|
|200-day moving average||$45.57|
|Wall St. target price||$62.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-3.08|
Buy DermTech shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy DermTech stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
DermTech price performance over time
|1 week (2021-07-23)||N/A|
|1 month (2021-07-02)||7.91%|
|3 months (2021-05-03)||1.94%|
|6 months (2021-01-30)||N/A|
|1 year (2020-07-30)||N/A|
|2 years (2019-07-30)||N/A|
|3 years (2018-07-30)||N/A|
|5 years (2016-07-30)||N/A|
|Revenue TTM||$6.9 million|
|Gross profit TTM||$-96,000|
|Return on assets TTM||-15.09%|
|Return on equity TTM||-26.85%|
|Market capitalisation||$973.8 million|
TTM: trailing 12 months
Shorting DermTech shares
There are currently 5.1 million DermTech shares held short by investors – that's known as DermTech's "short interest". This figure is 4.5% down from 5.3 million last month.
There are a few different ways that this level of interest in shorting DermTech shares can be evaluated.
DermTech's "short interest ratio" (SIR)
DermTech's "short interest ratio" (SIR) is the quantity of DermTech shares currently shorted divided by the average quantity of DermTech shares traded daily (recently around 926150.36363636). DermTech's SIR currently stands at 5.5. In other words for every 100,000 DermTech shares traded daily on the market, roughly 5500 shares are currently held short.
However DermTech's short interest can also be evaluated against the total number of DermTech shares, or, against the total number of tradable DermTech shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case DermTech's short interest could be expressed as 0.18% of the outstanding shares (for every 100,000 DermTech shares in existence, roughly 180 shares are currently held short) or 0.3122% of the tradable shares (for every 100,000 tradable DermTech shares, roughly 312 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against DermTech.
Find out more about how you can short DermTech stock.
DermTech share dividends
We're not expecting DermTech to pay a dividend over the next 12 months.
Have DermTech's shares ever split?
DermTech's shares were split on a 1:2 basis on 29 August 2019. So if you had owned 2 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your DermTech shares – just the quantity. However, indirectly, the new 100% higher share price could have impacted the market appetite for DermTech shares which in turn could have impacted DermTech's share price.
DermTech, Inc. , a molecular diagnostic company, develops and markets novel non-invasive genomics tests to diagnosis skin cancer, inflammatory diseases, and aging-related conditions in the United States. It offers Pigmented Lesion Assay (PLA), a gene expression test that helps rule out melanoma and the need for a surgical biopsy of atypical pigmented lesions. The company also provides Nevome test, an adjunctive reflex test for the PLA; and adhesive skin sample collection kits, as well as gene expression assays for the Th1, Th2, IFN-gamma, and Th17 inflammatory pathways. In addition, it is developing UV damage DNA risk assessment products, as well as non-melanoma skin cancer diagnostic and cutaneous T-cell lymphoma rule out test products, as well as offering health-related and information services through electronic information and telecommunication technologies. The company sells its products primarily to pathology and oncology practitioners. DermTech, Inc.
Stocks similar to DermTech
DermTech in the news
Will DermTech, Inc. (DMTK) Report Negative Earnings Next Week? What You Should Know
Were Hedge Funds Right About DermTech, Inc. (DMTK)?
DermTech to Announce Second Quarter Financial Results on August 4, 2021
Frequently asked questionsWhat percentage of DermTech is owned by insiders or institutions?
Currently 9.906% of DermTech shares are held by insiders and 73.7% by institutions. How many people work for DermTech?
Latest data suggests 114 work at DermTech. When does the fiscal year end for DermTech?
DermTech's fiscal year ends in December. Where is DermTech based?
DermTech's address is: 11099 North Torrey Pines Road, La Jolla, CA, United States, 92037 What is DermTech's ISIN number?
DermTech's international securities identification number is: US24984K1051 What is DermTech's CUSIP number?
DermTech's Committee on Uniform Securities Identification Procedures number is: 24984K105
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert